share_log

艾美疫苗:(經修訂) 截至二零二三年十一月三十日止之股份發行人的證券變動月報表

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

HKEX ·  May 7 04:31

Summary by Moomoo AI

艾美疫苗股份有限公司於2024年5月7日重新提交了截至2023年11月30日的證券變動月報表。報告顯示,公司的H股和內資股在11月份均無增減,H股結存為492,173,711股,內資股結存為718,888,888股。此外,公司首次公開發售前的僱員股份激勵計劃下,本月底結存的股份期權數目為11,170,000,較上月減少100,000。公司確認所有證券發行均已獲董事會授權,並符合香港聯合交易所有限公司證券上市規則的相關要求。
艾美疫苗股份有限公司於2024年5月7日重新提交了截至2023年11月30日的證券變動月報表。報告顯示,公司的H股和內資股在11月份均無增減,H股結存為492,173,711股,內資股結存為718,888,888股。此外,公司首次公開發售前的僱員股份激勵計劃下,本月底結存的股份期權數目為11,170,000,較上月減少100,000。公司確認所有證券發行均已獲董事會授權,並符合香港聯合交易所有限公司證券上市規則的相關要求。
EMERY VACCINES CO., LTD. REFILED ON MAY 7, 2024 ITS REPORT OF MONTHLY CHANGES IN SECURITIES FOR THE YEAR ENDED NOVEMBER 30, 2023. The report showed that the company's H shares and internal capital shares did not decrease in November, with 492,173,711 shares outstanding and 718,888,888 shares outstanding. In addition, the number of stock options outstanding at the end of this month was 11,170,000 under the company's employee share incentive program prior to its initial public offering, down 100,000 from the previous month. The Company confirms that all securities issuance has been authorised by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
EMERY VACCINES CO., LTD. REFILED ON MAY 7, 2024 ITS REPORT OF MONTHLY CHANGES IN SECURITIES FOR THE YEAR ENDED NOVEMBER 30, 2023. The report showed that the company's H shares and internal capital shares did not decrease in November, with 492,173,711 shares outstanding and 718,888,888 shares outstanding. In addition, the number of stock options outstanding at the end of this month was 11,170,000 under the company's employee share incentive program prior to its initial public offering, down 100,000 from the previous month. The Company confirms that all securities issuance has been authorised by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more